High rates of venous thromboembolism in endometrial cancer patients requiring systemic therapy: an opportunity for risk assessment and intervention

The authors aimed to evaluate the incidence of venous thromboembolism (VTE) among patients undergoing chemotherapy for endometrial cancer and identify associated risk factors. They found that 26.7% of the 292 patients developed VTE, with cancer stage at diagnosis being the only significant factor linked to VTE occurrence. The study highlights the need for improved risk assessment and potential prophylactic interventions in this high-risk population as endometrial cancer cases increase.